Insider · CIK 0001349376
Timothy P Walbert
director
Files at BMRN (BIOMARIN PHARMACEUTICAL INC), SGMT (Sagimet Biosciences Inc.), MIRM (Mirum Pharmaceuticals, Inc.), IPSC (Century Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 16, 2025 |
| Jun 9, 2025 | SGMT Sagimet Biosciences Inc. | AGrant or award Stock Option (Right to Buy)derivative | +32,250 | $0.00 | $0 | 32,250 | Jun 10, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +5,703 | - | - | 5,703 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,703 | $0.00 | $0 | 0 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +6,268 | $0.00 | $0 | 6,268 | Jun 2, 2025 |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +3,977 | $0.00 | $0 | 3,977 | Jun 2, 2025 |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +6,650 | $0.00 | $0 | 9,780 | May 22, 2025 |
| Feb 24, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +3,130 | $0.00 | $0 | 3,130 | Feb 26, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.